SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-011656
Filing Date
2020-05-11
Accepted
2020-05-11 16:32:31
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_intecpharma.htm 10-Q 272369
2 CERTIFICATION f10q0320ex31-1_intec.htm EX-31.1 15433
3 CERTIFICATION f10q0320ex31-2_intec.htm EX-31.2 14997
4 CERTIFICATION f10q0320ex32-1_intec.htm EX-32.1 7072
5 CERTIFICATION f10q0320ex32-2_intec.htm EX-32.2 6023
  Complete submission text file 0001213900-20-011656.txt   1771060

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ntec-20200331.xml EX-101.INS 207329
7 XBRL SCHEMA FILE ntec-20200331.xsd EX-101.SCH 37795
8 XBRL CALCULATION FILE ntec-20200331_cal.xml EX-101.CAL 37199
9 XBRL DEFINITION FILE ntec-20200331_def.xml EX-101.DEF 99191
10 XBRL LABEL FILE ntec-20200331_lab.xml EX-101.LAB 192304
11 XBRL PRESENTATION FILE ntec-20200331_pre.xml EX-101.PRE 152129
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37521 | Film No.: 20865349
SIC: 2834 Pharmaceutical Preparations